Kenn Samala· @KSamalaMD · X·· 1 day agoScore70
Body
Temab-A : a novel anti c-met protein ADC #ESMO26
16 views · 0 likes · 0 reposts · 1 reply
Conference abstracts
1017Pmatched by Developmental therapeutics
Phase 1 first-in-human (FIH) results of YL211, a c-Met targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors
https://esmocongress.esmo.orgNCT06110663NCT06110663matched by - **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.orgReplies in this thread
- Kenn Samala@KSamalaMD
Median PFS was 6.8 mos and median OS was 13.8 in the overall EGFRwt cohort #ESMO26
Source: Kenn Samala · x.com